Haga Hospital

Running trials

• Recruiting

  A Study to Evaluate the Efficacy of VVD-133214 in Combination With Pembrolizumab Compared With Pembrolizumab Alone in Participants With Advanced Cancer of the Colon or Rectum

  NCT07811193· Phase 2· Vividion Therapeutics, Inc.· Source

• Recruiting

  Parasternal Extravascular ICD System Pivotal Clinical Investigation (ALARION EV) Study

  NCT07324031· AtaCor Medical, Inc.· Source

• Recruiting

  Adaptive vs. Continuous Subthalamic Nucleus Deep Brain Stimulation in Parkinson's Disease

  NCT06909045· Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)· Source

• Recruiting

  VT Ablation in the iCMR

  NCT05543798· Imricor Medical Systems· Source

• Recruiting

  The Beneficial Value of PET/CT in the Follow-up of Stage III Non-small Cell Lung Cancer Patients

  NCT06082492· Radboud University Medical Center· Source

• Recruiting

  Drug Rediscovery for Rare Immune Mediated Inflammatory Diseases

  NCT06285539· Phase 2· UMC Utrecht· Source

• Recruiting

  Apa/Enza-short Study: Shorter Treatment With Androgen Receptor Pathway Inhibitor in Patients With Low-volume Metastatic Castration-sensitive Prostate Cancer

  NCT07260435· Phase 3· Nick Beije· Source

• Recruiting

  The Effect of exeRcise And Diet on Quality of Life in Patients With Incurable Cancer of Esophagus and Stomach (RADICES)

  NCT06138223· Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)· Source

• Active, not recruiting

  Tislelizumab, Gemcitabine and Cisplatin for R/R Hodgkin Lymphoma Followed by Tislelizumab Consolidation in Patients in Metabolic Complete Remission

  NCT05502250· Phase 2· Stichting Hemato-Oncologie voor Volwassenen Nederland· Source

• Recruiting

  Observational Dutch Young Symptomatic StrokE studY - nEXT

  NCT05853796· Radboud University Medical Center· Source

• Recruiting

  Comparison Of Reduced DAPT Followed by P2Y12 Inhibitor Monotherapy With Prasugrel vs stAndard Regimen in STEMI Patients

  NCT05491200· Phase 4· Research Maatschap Cardiologen Rotterdam Zuid· Source

• Active, not recruiting

  SEQUence of Endocrine Therapy in Advanced Luminal Breast Cancer (SEQUEL-Breast)

  NCT05392608· Phase 2· Borstkanker Onderzoek Groep· Source

• Active, not recruiting

  Prospective Observational Study of Filgotinib in Subjects With Rheumatoid Arthritis

  NCT04871919· Alfasigma S.p.A.· Source

• Active, not recruiting

  SMall Annuli Randomized To Evolut™ or SAPIEN™ Trial

  NCT04722250· Medtronic Cardiovascular· Source

• Recruiting

  PSMA-PET Guided Hypofractionated Salvage Prostate Bed Radiotherapy

  NCT04642027· Phase 3· University Medical Center Groningen· Source

• Active, not recruiting

  A Study of Gilteritinib Versus Midostaurin in Combination With Induction and Consolidation Therapy Followed by One-year Maintenance in Patients With Newly Diagnosed Acute Myeloid Leukemia or Myelodysplastic Syndromes With Excess Blasts-2 With FLT3 Mutations Eligible for Intensive Chemotherapy

  NCT04027309· Phase 3· Stichting Hemato-Oncologie voor Volwassenen Nederland· Source

• Active, not recruiting

  The Feasibility and Clinical Efficacy of Atezolizumab Consolidation Treatment in High Risk (IPI > 2) DLBCL

  NCT03463057· Phase 2· Stichting Hemato-Oncologie voor Volwassenen Nederland· Source

• Active, not recruiting

  HOVON 152 DLBCL. A phase II study evaluating the effect of DA-EPOCH-R induction followed by nivolumab consolidation in patients with newly diagnosed high grade B cell lymphoma (HGBL) with MYC and BCL2 and/or BCL6 rearrangements

  NCT03620578· Phase 2· Stichting Hemato-Oncologie voor Volwassenen Nederland (Hovon)· Source

• Active, not recruiting

  Endocrine Therapy Plus CDK4/6 in First or Second Line for Hormone (SONIA) Receptor Positive Advanced Breast Cancer

  NCT03425838· Phase 3· Borstkanker Onderzoek Groep· Source

• Recruiting

  Prospective Data Collection Initiative on Colorectal Cancer

  NCT02070146· Dutch Colorectal Cancer Group· Source

• Active, not recruiting

  Rectal Cancer And Pre-operative Induction Therapy Followed by Dedicated Operation. The RAPIDO Trial

  NCT01558921· Phase 3· University Medical Center Groningen· Source

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Colorectal cancer2 recruiting
• Prostate cancer2 recruiting
• Ventricular tachycardia2 recruiting
• Coronary artery disease1 recruiting
• Dermatomyositis and polymyositis (myositis)1 recruiting
• Gastric and oesophageal cancer1 recruiting
• Lung cancer1 recruiting
• Parkinson disease1 recruiting
• Stroke1 recruiting

Closed trials

• Completed

  Real Life Lipid Management in Hospitals Not Participating in PENELOPE Trial - Control Population for PENELOPE

  NCT05659888· Clinical Operations WCN B.V.· Source

• Terminated

  Study of Magrolimab Versus Placebo in Combination With Venetoclax and Azacitidine in Participants With Acute Myeloid Leukemia

  NCT05079230· Phase 3· Gilead Sciences· Source

• Terminated

  HC-1119 Versus Enzalutamide in Metastatic Castration-Resistant Prostate Cancer (mCRPC)

  NCT03850795· Phase 3· Hinova Pharmaceuticals USA, Inc.· Source

• Completed

  Periprocedural Continuation Versus Interruption of Oral Anticoagulant Drugs During Transcatheter Aortic Valve Implantation (POPular PAUSE TAVI)

  NCT04437303· Phase 4· St. Antonius Hospital· Source

• Completed

  Synergetic B-cell Immunomodulation in SLE - 2nd Study.

  NCT03747159· Phase 3· Leiden University Medical Center· Source

• Completed

  The TransCatheter Valve and Vessels Trial

  NCT03424941· Maatschap Cardiologie Zwolle· Source

• Completed

  Colchicine and Spironolactone in Patients with MI / SYNERGY Stent Registry

  NCT03048825· Phase 3· Population Health Research Institute· Source

• Completed

  Experiences and Health-related Quality of Life of Informal Caregivers of Dialysis Patients

  NCT05646615· B.C. van Jaarsveld· Source

• Completed

  Trial to Assess Safety and Efficacy of Lenvatinib (18 mg vs. 14 mg) in Combination With Everolimus in Participants With Renal Cell Carcinoma

  NCT03173560· Phase 2· Eisai Inc.· Source

• Completed

  A Comparison of Fractional Flow Reserve-Guided Percutaneous Coronary Intervention and Coronary Artery Bypass Graft Surgery in Patients With Multivessel Coronary Artery Disease

  NCT02100722· Stanford University· Source

• Completed

  Treatment Strategies in Colorectal Cancer Patients With Initially Unresectable Liver-only Metastases

  NCT02162563· Phase 3· Dutch Colorectal Cancer Group· Source

• Completed

  R-CHOP + R-HAD vs R-CHOP Followed by Maintenance Lenalidomide + Rituximab vs Rituximab for Older Patients With MCL

  NCT01865110· Phase 3· The Lymphoma Academic Research Organisation· Source

Conditions

Diseases this institution publishes on or runs trials for.

• Barrett's oesophagus4 works · 0 trials